中国血液流变学杂志
中國血液流變學雜誌
중국혈액류변학잡지
CHINESE JOURNAL OF HEMORHEOLOGY
2014年
2期
235-236,267
,共3页
复方阿嗪米特%复合乳酸菌胶囊%腹泻型肠易激综合征
複方阿嗪米特%複閤乳痠菌膠囊%腹瀉型腸易激綜閤徵
복방아진미특%복합유산균효낭%복사형장역격종합정
compound azintamide%lactobacillus complex capsule%diarrhea-predominant pattern irritable bowel syndrome
目的：观察复方阿嗪米特联合复合乳酸菌胶囊治疗腹泻型肠易激综合征（IBS）的临床疗效。方法将108例腹泻型IBS患者随机分为治疗组（A组，n=54）和对照组（B组，n=54）。A组给予复方阿嗪米特肠溶片联合复合乳酸菌胶囊口服。B组采用复合乳酸菌胶囊口服。2组均治疗4周后观察疗效。结果总有效率A组为87.0%，B组64.8%，差异有统计学意义（P＜0.05）。结论复方阿嗪米特联合复合乳酸菌胶囊治疗腹泻型IBS较单纯复合乳酸菌胶囊疗效更为显著，值得进一步研究和临床推广。
目的：觀察複方阿嗪米特聯閤複閤乳痠菌膠囊治療腹瀉型腸易激綜閤徵（IBS）的臨床療效。方法將108例腹瀉型IBS患者隨機分為治療組（A組，n=54）和對照組（B組，n=54）。A組給予複方阿嗪米特腸溶片聯閤複閤乳痠菌膠囊口服。B組採用複閤乳痠菌膠囊口服。2組均治療4週後觀察療效。結果總有效率A組為87.0%，B組64.8%，差異有統計學意義（P＜0.05）。結論複方阿嗪米特聯閤複閤乳痠菌膠囊治療腹瀉型IBS較單純複閤乳痠菌膠囊療效更為顯著，值得進一步研究和臨床推廣。
목적：관찰복방아진미특연합복합유산균효낭치료복사형장역격종합정（IBS）적림상료효。방법장108례복사형IBS환자수궤분위치료조（A조，n=54）화대조조（B조，n=54）。A조급여복방아진미특장용편연합복합유산균효낭구복。B조채용복합유산균효낭구복。2조균치료4주후관찰료효。결과총유효솔A조위87.0%，B조64.8%，차이유통계학의의（P＜0.05）。결론복방아진미특연합복합유산균효낭치료복사형IBS교단순복합유산균효낭료효경위현저，치득진일보연구화림상추엄。
Objective To investigate the curative effect of compound azintamide enteric coated tablet combined with lactobacillus complex capsule for diarrhea-predominant pattern irritable bowel syndrome. Methods 108 patients with diarrhea-predominant pattern irritable bowel syndrome were randomized into treatment group (n=54, group A, treated with compound azintamide enteric coated tablet combined with lactobacillus complex capsule), and control group (n=54, group B, treated with lactobacillus complex capsule only). The two groups were treated for four weeks, and the curative effects were observed. Results The total effective rate were 87.0%in group A, and 64.8%in group B with significant difference (P<0.05). Conclusion The curative effect of compound azintamide enteric coated tablet combined with lactobacillus complex capsule was more significant than that of lactobacillus complex capsule used alone. It is worthy of further research and clinical promotion.
